Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL35AP37 is a *pseudogene* related to ribosomal protein L35a. Pseudogenes refer to genomic DNA sequences similar to normal genes but typically non-functional due to mutations or truncations. They may not be transcribed or translated and rarely encode proteins. While certain pseudogenes have regulatory roles in the context of gene expression via non-coding RNAs (for example, by acting as microRNA sponges), most ribosomal protein pseudogenes—including RPL35AP37—have not had such a role documented. There is no current evidence suggesting RPL35AP37 contributes to disease, interacts with drugs, or functions as a biomarker. Its identification in gene databases reflects its similarity to ribosomal protein L35a but does not imply any functional or pathogenic role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L35a pseudogene 37 (RPL35AP37).